研報掘金丨財通證券:繼峯股份持續獲得座椅總成定點,維持“增持”評級
財通證券研報指出,繼峯股份(603997.SH)持續獲得座椅總成定點,客户認可助力發展。2024年至今,公司已經獲得9 個乘用車座椅總成定點。截至目前,公司公吿乘用車座椅總成在手定點已達21個。本次新獲定點項目是原客户將其他車型再次定點給公司。公司再次獲得原客户項目定點,體現了客户對公司在合作過程中體現的能力和提供的服務的認可,同時在手訂單的不斷積累,也為公司將來的生產形成規模經濟創造了條件。同時,格拉默在繼峯的統籌協調下,獲得奧迪、一汽大眾等多個乘用車座椅項目定點,進一步夯實公司的乘用車座椅全球戰略基礎。維持“增持”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.